Research Topics
Genomes and GenesSpecies | Ali TaherSummaryAffiliation: American University of Beirut Country: Lebanon Publications
| Collaborators
|
Detail Information
Publications
Thalassemia intermedia: revisitedAli Taher
Department of Internal Medicine, Hematology Oncology Division, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon
Blood Cells Mol Dis 37:12-20. 2006..Here, we review the major clinical complications in thalassemia intermedia and suggest some therapeutic strategies based on retrospective clinical observations...
Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled studyAli T Taher
American University of Beirut, Beirut, Lebanon
Blood 120:970-7. 2012..8%), and diarrhea (n = 6; 3.6%). This is the first randomized study showing that iron chelation with deferasirox significantly reduces iron overload in NTDT patients with a frequency of overall adverse events similar to placebo...
Mechanisms of renal disease in β-thalassemiaKhaled M Musallam
Department of Medicine and Medical Specialties, IRCCS Cà Granda Foundation Maggiore Policlinico Hospital, Milan, Italy
J Am Soc Nephrol 23:1299-302. 2012..Nonprogressive increases in levels of serum creatinine have also been observed after exposure to some iron chelators. Longitudinal studies are needed to understand the true burden of renal dysfunction in patients with β-thalassemia...
Contemporary approaches to treatment of beta-thalassemia intermediaAli T Taher
American University of Beirut Medical Center, Beirut, Lebanon
Blood Rev 26:S24-7. 2012..This review describes the current state of the art for medical management of TI, with particular focus on the roles of splenectomy, transfusion, and iron chelation therapy...
Burkitt's lymphoma of the colon and bronchi: three case reportsKhaled M Musallam
Department of Internal Medicine, Hematology Oncology Division, P, O, Box 11 0236, American University of Beirut Medical Center, Beirut, Lebanon
Cases J 1:15. 2008..abstract:..
Solitary mediastinal lymph node metastasis in rectosigmoid carcinoma: a case reportKhaled M Musallam
Department of Internal Medicine, Hematology Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon
Cases J 1:69. 2008..abstract:..
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overloadAli Taher
Department of Internal Medicine, Haematology Oncology Division, American University of Beirut, Medical Centre, Beirut, Lebanon
Br J Haematol 147:752-9. 2009..This has important implications for patients who are heavily transfused and may require higher doses to reduce body iron burden...
Thalassemia and hypercoagulabilityAli T Taher
Hematology Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Blood Rev 22:283-92. 2008..We also discuss the recommendations for thrombosis prophylaxis in these patients...
The hypercoagulable state in thalassemia intermediaAli T Taher
Department of Internal Medicine, Hematology Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon
Hemoglobin 33:S160-9. 2009..Recommendations for thrombosis prophylaxis in these patients are also discussed...
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE studyAli T Taher
Department of Internal Medicine, Hematology Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon
Blood 115:1886-92. 2010..This study provides evidence that calls for prospective evaluation of the roles of transfusion, iron chelation, and hydroxyurea therapy in TI patients...
Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-Thalassemia: Results from the ESCALATOR TrialAli Taher
American University of Beirut, Lebanon
Acta Haematol 123:220-5. 2010..Patients reported greater satisfaction and convenience, and lower impact on daily activities, with deferasirox than with previous ICT. This may help improve adherence to lifelong ICT in iron-overloaded beta-thalassemia patients...
The AVAIL ME study: a multinational survey of VTE risk and prophylaxisAli T Taher
Hematology Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, PO Box 11 0236, Riad El Solh, 1107 2020 Beirut, Lebanon
J Thromb Thrombolysis 31:47-56. 2011..16 was found between eligibility for VTE prophylaxis on one hand and its application in practice (P < 0.001). Risk factors for VTE and eligibility for VTE prophylaxis are common, but VTE prophylaxis and guidelines application are low...
Iron overload in thalassaemia intermedia: reassessment of iron chelation strategiesAli Taher
Department of Internal Medicine, Haematology Oncology Division, American University of Beirut, Medical Centre, Beirut, Lebanon
Br J Haematol 147:634-40. 2009..Better understanding of the need to assess and treat iron overload in both transfused and non-transfused TI patients is clearly required...
Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermediaAli Taher
Department of Internal Medicine, Haematology Oncology Division, American University of Beirut Medical Centre, Beirut, Lebanon
Br J Haematol 146:569-72. 2009..36; P = 0.002) and serum ferritin (Pearson correlation 0.421; P < 0.0001); with higher levels observed in splenectomised patients. NTBI assessment has potential as a simple reliable approach to determining iron status in TI...
Ocular findings among thalassemia patientsAli Taher
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Am J Ophthalmol 142:704-5. 2006..The study aims at studying the ophthalmologic status in a group of thalassemia patients...
Effects of divalproex sodium on hemoglobin levelAli T Taher
Department of Internal Medicine, Division of Hematology Oncology, American University of Beirut Medical Center, Beirut, Lebanon
Blood Cells Mol Dis 43:49-52. 2009..Hb increase was evident in 47.0% of values. A clinically relevant increase in Hb (>0.5 g/dL) occurred in 23.9% of values. VPA is associated with a change in total Hb level that correlates inversely with baseline Hb levels...
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR studyAli Taher
Department of Internal Medicine, Hematology, Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon
Eur J Haematol 82:458-65. 2009..Phase II/III studies have shown that oral deferasirox 20-30 mg/kg/d reduces iron burden, depending on transfusional iron intake...
Iron overload in thalassemia and sickle cell diseaseA Taher
Hematology and Oncology, American University of Beirut Medical Center, Beirut, Lebanon
Semin Hematol 42:S5-9. 2005
Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: a two-year studyAli Taher
American University of Beirut Medical Center, Beirut, Lebanon
Acta Haematol 114:146-9. 2005..05). Liver iron levels at the end of the 2-year study ranged from 1.0 to 30.9 mg/g dry weight, 3 of the patients having levels above 15 mg/g...
Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermediaA T Taher
Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
J Thromb Haemost 8:54-9. 2010..Brain involvement has not been widely studied in TI, although limited reports confirm a low incidence of overt stroke and high incidence of silent brain infarcts...
Optimal management of β thalassaemia intermediaAli T Taher
Department of Internal Medicine, Division of Haematology and Oncology, American University of Beirut Medical Centre, Riad El Solh 1107 2020, Beirut, Lebanon
Br J Haematol 152:512-23. 2011..Until solid evidence-based guidelines are available, individualised treatment should be entertained...
Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature reviewA Taher
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Am J Hematol 63:90-3. 2000..This risk should be seriously taken into consideration when prescribing ticlopidine. G-CSF may be helpful in the treatment of ticlopidine-induced aplastic anemia...
Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patientsA Taher
The Chronic Care Centre, The American University of Beirut Medical Centre, Beirut, Lebanon
Eur J Haematol 67:30-4. 2001..However, the limitations of this treatment have stimulated the design of alternative orally active iron chelators...
Extramedullary hematopoiesis in a patient with beta-thalassemia intermedia manifesting as symptomatic pleural effusionA Taher
Division of Hematology Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Lebanon
Hemoglobin 25:363-8. 2001..The pleural effusion was controlled by pleurodesis using tetracycline. We review the literature on this uncommon complication of beta-thalassemia intermedia and discuss the options for diagnosis and treatment...
Iron overload: consequences, assessment, and monitoringAli T Taher
Department of Internal Medicine, Hematology Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon
Hemoglobin 33:S46-57. 2009..Optimal iron overload assessment and monitoring is a key element in the development of improved strategies of iron chelation therapy that can be tailored to meet the patient's specific needs...
Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR studyAli Taher
American University of Beirut Medical Center, Beirut, Lebanon
Eur J Haematol 87:349-54. 2011..4 ± 5.2 mg/kg/d and significantly reducing LIC in patients with LIC ≥ 7 mg Fe/g dw at a mean dose of 25.7 ± 4.2 mg/kg/d, along with a manageable safety profile...
Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication?Ali Taher
Department of Internal Medicine, American University of Beirut Medical Center, Lebanon
Hemoglobin 26:107-12. 2002..A significant relationship between pulmonary thromboembolism and pulmonary hypertension in these patients was noted...
Importance of optimal dosing ≥ 30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemiaAli Taher
American University of Beirut Medical Center, Beirut, Lebanon
Eur J Haematol 87:355-65. 2011..44.3%). Doses ≥ 30 mg/kg/d were generally required because of high transfusional iron intake and high baseline serum ferritin levels, highlighting the importance of administering an adequate dose to achieve net negative iron balance...
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermediaKhaled M Musallam
Department of Internal Medicine, Division of Hematology and Oncology, American University of Beirut Medical Center, Beirut, Lebanon
Haematologica 96:1605-12. 2011..This study evaluates whether iron overload in patients with β thalassemia intermedia is associated with morbidity...
Frequency of triple mutations involving factor V, prothrombin, and methylenetetrahydrofolate reductase genes among patients referred for molecular thrombophilia workup in a tertiary care center in LebanonRouba Hoteit
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Genet Test Mol Biomarkers 16:223-5. 2012....
A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC)Ali Shamseddine
Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
Am J Clin Oncol 28:393-8. 2005..This report is a pilot study assessing the antitumor efficacy and safety of this regimen as first line therapy for advanced breast cancer patients...
Beta-thalassemia intermedia: an overviewFuad El Rassi
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Pediatr Ann 37:322-8. 2008
Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermediaHussain Isma'eel
Department of Internal Medicine Hematology Oncology Division, American University of Beirut, Medical Center, Beirut, Lebanon
Am J Cardiol 102:363-7. 2008....
Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patientsFadi H Mourad
Department of Internal Medicine, The American University of Beirut Medical Centre, Beirut, Lebanon
Br J Haematol 121:187-9. 2003..Main side-effects were skin reactions (DFX alone), nausea and arthralgia (combined therapy). As chelation therapy, the combined protocol was as effective as DFX five times weekly...
Cisplatin and vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of experienceAli Shamseddine
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
J Med Liban 52:126-30. 2004..Our data will be compared with other groups using the same regimen for the management of advanced breast carcinoma...
Absence of JAK2 V617F mutation in thalassemia intermedia patientsAli Taher
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Mol Biol Rep 36:1555-7. 2009..The latter's V617F mutation does not seem to play a role in this hematologically important clinical entity...
Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and IranAli Taher
Internal Medicine, American University of Beirut, Beirut, Lebanon
Thromb Haemost 96:488-91. 2006..Due to the increased risk of thromboembolic events, the rationale for splenectomy should perhaps be re-assessed and the role of transfusion therapy for the prophylaxis of thrombosis, among other complications, be evaluated prospectively...
Peripheral neuropathy in thalassaemiaRaja A Sawaya
Department of Internal Medicine, American University Medical Center, Beirut, Lebanon
Ann Saudi Med 26:358-63. 2006..The aim of the study was to document whether these patients suffer from a polyneuropathy and to determine any contributing factors for the development of neuropathy...
Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical CenterAli Shamseddine
Department of Internal Medicine, American University of Beirut Medical Center, Lebanon
J Clin Apher 19:119-24. 2004..3%. TTP remains a fatal disease. A high index of suspicion should, therefore, always be present. Treatment options should be further developed and patients should directly be referred to tertiary care centers...
Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infectionAdlette Inati
Chronic Care Center, American University of Beirut Medical Center, Beirut, Lebanon
Br J Haematol 130:644-6. 2005..05). Transfusion requirements rose by 34% in the combination arm (P=0.08). Peginterferon/ribavirin was effective in thalassaemics with HCV and moderate iron overload...
Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese peopleMaria O Esmerian
Pharmacology and Therapeutics, Faculty of Medicine, American University of Beirut, Riad El Solh, Beirut 1107 2020, Lebanon
J Clin Pharmacol 51:1418-28. 2011....
Concomitant occurrence of kimura disease and mycosis fungoides in a Lebanese woman: significance and response to rituximabSamer Ghosn
Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon
Am J Dermatopathol 31:814-8. 2009..Although the KD lesions persisted, they became softer and less nodular. As for the MF lesions, they flared transiently and then exhibited a sustained improvement over a follow-up period of 1 year...
Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care centerRamy Masroujeh
Department of Internal Medicine, American University of Beirut Medical Center, P O Box 11 0236, Riad El Solh, Beirut, 1107 2020, Lebanon
J Thromb Thrombolysis 26:138-41. 2008..This study aims at assessing how much house-staff in a tertiary care setting are implementing these new recommendations in the hope that through quantitative analysis of the deficiency we would be able to identify areas of weakness...
Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical CenterElie Aoun
Department of Internal Medicine, American Universitty of Beirut--Medical Center, Beirut, Lebanon
Transfusion 43:1672-6. 2003..The mortality rate was 100 percent. CONCLUSION: TA-GVHD is a serious complication with very high mortality. Effective prevention guidelines should be established in Lebanon including irradiation and the creation of a central blood bank...
JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in LebanonRami A R Mahfouz
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Genet Test Mol Biomarkers 15:263-5. 2011..This report is the first of its kind from Lebanon that analyzes the distribution of this mutation among a series of referred cases to a major tertiary referral center...
Hypertransfusion: a successful method of treatment in thalassemia intermedia patients with spinal cord compression secondary to extramedullary hematopoiesisAref Chehal
American University of Beirut Medical Center, Beirut, Lebanon
Spine 28:E245-9. 2003..Hypertransfusion seems to be a promising treatment method that should be recommended as a first-line approach or as an adjuvant therapy to other methods...
Five-year trial of deferiprone chelation therapy in thalassaemia major patientsA Taher
Department of Internal Medicine, American University of Beirut, Medical Center, Beirut, Lebanon
Acta Haematol 112:179-83. 2004..In a minority, higher doses of deferiprone or a combination with desferrioxamine would be needed to lower liver iron below 15 mg/g...
Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in LebanonA Inati
Hematology Unit, Chronic Care Center, Beirut, Lebanon
Eur J Haematol 70:79-83. 2003..In addition, the high levels of HbF in patients with CAR haplotypes did not seem to ameliorate the severity of symptoms, suggesting that genetic factors other than haplotypes are the major determinants of increased HbF levels in Lebanon...
Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatmentJinane El Khoury
Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon
Int Wound J 9:344-7. 2012..In this study, we describe, to the best of our knowledge, the first report of LV only associated with sickle cell trait with significant improvement on aspirin...
The hematologic manifestations of the antiphospholipid syndromeImad Uthman
Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
Blood Rev 22:187-94. 2008..A high index of suspicion is needed for the early recognition and treatment of these conditions...
Sickle cell disease: new insights into pathophysiology and treatmentAdlette Inati
Rafik Hariri University Hospital, Division of Pediatric Hematology and Oncology, Beirut, Lebanon
Pediatr Ann 37:311-21. 2008
Hb H disease and multiple myelomaIhab Elhajj
Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut, Beirut, Lebanon
Hemoglobin 28:79-82. 2004
Massive pulmonary embolism in a Lebanese patient doubly heterozygous for MTHFR and Factor V Leiden presenting with syncope and treated with tenecteplaseAli Taher
American University of Beirut Medical Center, P.O. Box: 11- 0236/A19, Riad El Solh, 11072020, Beirut, Lebanon
J Thromb Thrombolysis 21:179-84. 2006
Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancerAref Chehal
Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Box 113-6044, Beirut 1107 2802, Lebanon
Breast 13:421-4. 2004..In this paper, we report on a patient with advanced breast cancer who attained complete response of 14 months duration to a cisplatin/vinorelbine combination after progression during treatment with paclitaxel and doxorubicin...
Anticardiolipin antibodies in patients with retinal vein occlusion and no risk factors: a prospective studyZiad F Bashshur
Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon
Retina 23:486-90. 2003..The purpose of this study was to look at the prevalence of these antibodies in patients with RVO disease and no conventional risk factors. We specifically examined how APAs may affect the course of this disease...
Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemicsS Ramia
Faculty of Health Sciences, American University of Beirut, Lebanon
Ann Trop Med Parasitol 96:197-202. 2002..This and stringent infection-control measures are necessary steps to limit the spread of HBV, HCV and perhaps HGV to thalassaemics...
Hughes syndrome associated with varicella infectionI Uthman
American University of Beirut, Medical Center, Lebanon
Rheumatol Int 20:167-8. 2001..IgM and IgG anticardiolipin (aCL) were both positive upon admission. The IgM aCL antibodies were still positive 6 weeks later, which suggests their role as a predisposing factor of deep vein thrombosis...
Beta-thalassemia mutations and haplotype analysis in LebanonL Zahed
Department of Pathology and Laboratory Medicine, American University of Beirut, Lebanon
Hemoglobin 24:269-76. 2000..The five most common mutations were each found on two different haplotypes, and most linkages were as previously reported in other Mediterranean populations, with a few exceptions, also showing some clustering...
A comparison between prophylaxis and on demand treatment for severe haemophiliaR Khoriaty
Khatharine Dormandy Haemophilia Centre, Royal Free Hampstead NHS Trust, London, UK
Clin Lab Haematol 27:320-3. 2005..4). This suggests that prophylaxis reduces the risk of arthropathies, the number of future hospital visits and orthopaedic surgeries, and is thus the optimal modality of treatment for patients with severe haemophilia...
Campylobacter fetus pericarditis in a patient with beta-thalassemia: case report and review of the literatureS S Kanj
Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut, PO Box 113 6044, Beirut, Lebanon
Clin Microbiol Infect 7:510-3. 2001..Pericarditis due to C. fetus has rarely been reported. A high index of suspicion is essential to recognise this organism, because of its special microbiological characteristics...
Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibodyYasser Abou Mourad
Department of Internal Medicine, American University of Beirut-Medical Center, Box 113-6044, 1107 2802, Beirut, Lebanon
Ann Hematol 83:319-21. 2004..She remains in complete remission 8 months following the discontinuation of treatment. This is the second reported case of successful treatment of B-cell PLL with rituximab...
Gaucher disease: different clinical manifestations associated with a rare mutation (R48W) in a Lebanese familyLara M El-Zahabi
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Mol Genet Metab 91:402-4. 2007..Our patients' clinical course is described. We also review the English literature for patients with this rare mutation...
High prevalence of MTHFR gene A1298C polymorphism in LebanonAmira S Sabbagh
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Genet Test 12:75-80. 2008....
Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature reviewAli Shamseddine
Division of Hematology Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
J Clin Apher 19:5-10. 2004..Review of the previously reported cases of pregnancy-related TTP and the current treatment options for this rare condition are discussed also...
Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a caseImad Uthman
Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon
Dermatology 216:257-9. 2008
Report of a rare co-incidence of congenital factor V deficiency and thalassemia intermedia in a familyYasser Abou Mourad
Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut-Medical Center, Beirut, Lebanon
Ann Saudi Med 24:301-2. 2004
Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentationNagi S El Saghir
Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
J Med Liban 50:3-9. 2002..Earlier studies showed that it sees about one third of all cancer cases in Lebanon...
Moyamoya syndrome with intraventricular hemorrhage in an adult with factor V Leiden mutationRosette Jabbour
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Arch Neurol 62:1144-6. 2005..To report a case of proximal occlusion of 2 major cerebral vessels associated with moyamoya network circulation that manifested by spontaneous intraventricular hemorrhage...
The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndromeImad Uthman
Department of Internal Medicine, Division of Rheumatology, American University of Beirut Medical Center (AUBMC, Hamra Street, Beirut 1107 2802, Lebanon
Transfus Apher Sci 33:11-7. 2005..The use of this technique, along with anticoagulation and if needed pharmacological immunosuppression, should be considered for the acute management of patients who present with this life-threatening condition...
Pregnancy outcome in women with prosthetic heart valvesAnwar H Nassar
Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Lebanon
Am J Obstet Gynecol 191:1009-13. 2004..Despite a high maternal morbidity rate, the perinatal outcome is acceptable when pregnancy progresses beyond the first trimester...
Challenges associated with prolonged survival of patients with thalassemia: transitioning from childhood to adulthoodKhaled Musallam
Faculty of Medicine, American University of Beirut Medical Center, Riad El Solh 1107 2020, Beirut, Lebanon
Pediatrics 121:e1426-9. 2008..These issues and our recommendations for handling them are discussed...
Deep venous thrombosis in a patient with Behçet's disease and homozygous prothrombin (factor II) G20210A mutation on oral contraceptive pillsImad Uthman
Department of Internal Medicine, Faculty of Medicine, American University of Beirut Medical Center, 113 6044, Beirut, Lebanon
Rheumatol Int 26:758-9. 2006..Our case suggests that a thrombophilia work-up may be warranted in BD patients, especially young women before they are prescribed oral contraceptives...
The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?Elias Kfoury
Department of Surgery, American University of Beirut Medical School, Beirut, Lebanon
Mol Biol Rep 36:1041-51. 2009..This topic is gaining more and more importance for both surgeons and internists (especially Hematologists) and we, herein, present a general review of the published literature as an update on the subject...
Severe hemophagocytic syndrome developing after treatment initiation for disseminated Mycobacterium tuberculosis: case report and literature reviewMaher M Balkis
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Scand J Infect Dis 41:535-7. 2009..Later, while on anti-tuberculous treatment, he developed pancytopenia and bone marrow aspirate showed large macrophages with increased phagocytosis of mature and immature blood elements typical of hemophagocytic syndrome...
Current understanding in the management of sickle cell diseaseAdlette Inati
Division of Pediatric Hematology Oncology, Rafik Hariri University Hospital, Beirut, Lebanon
Hemoglobin 33:S107-15. 2009..This article will highlight modern management of SCD and its impact on the lives of affected patients...
Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosisImad Uthman
Department of Internal Medicine, Faculty of Medicine, Medical Center, American University of Beirut, Beirut, Lebanon
Clin Rheumatol 23:362-3. 2004..The detection of such abnormalities may have major practical consequences for the long-term management of these patients to prevent further thrombotic episodes...
A review of the off-label use of recombinant activated factor VII in a developing country tertiary care centerRamzi El Accaoui
American University of Beirut Medical Center, Beirut, Lebanon
Blood Coagul Fibrinolysis 17:647-50. 2006..Although off-label use of rFVIIa at AUB MC was supported by published reports, and associated with few complications, guidelines are required to control use of this medication...
Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized careK Charafeddine
American University of Beirut Medical Center, Beirut, Lebanon
Acta Haematol 120:112-6. 2008..The introduction of new oral iron chelators and better iron overload quantitation methods will most likely modify this picture, and a follow-up study will examine their impact...
Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassaemia patientsL Zahed
Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Lebanon
Haematologia (Budap) 31:333-9. 2002..Evaluation of a larger sample of patients over a longer period of time is needed in order to confirm the favourable results obtained in this study...
Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent population migrationN J Makhoul
Department of Obstetrics and Gynecology, American University of Beirut, Beirut, Lebanon
Ann Hum Genet 69:55-66. 2005..This study provides information about the types and distribution of beta-thalassemia mutations within each religious group and geographic region, which is essential for the implementation of screening and prevention programs...
Sickle cell disease: the Lebanese experienceA Inati
Division of Pediatric Hematology Oncology, Rafik Hariri University Hospital, Beirut, Lebanon
Int J Lab Hematol 29:399-408. 2007....
Beta-thalassemia intermedia and non-Hodgkin's lymphomaAref Chehal
Department of Internal Medicine, American University of Beirut, Lebanon
Hemoglobin 26:219-25. 2002..On reviewing the literature, only four cases of thalassemia and lymphoma have been reported worldwide, thus making our case the fifth report of this rare combination of diseases...
Novel mutation, L371V, causing multigenerational Gaucher disease in a Lebanese familyA Shamseddine
Department of Internal Medicine, Hematology Oncology Division, American University of Beirut, Lebanon
Am J Med Genet A 125:257-60. 2004..It is unknown whether L371V is a private mutation limited to this family, or will prove to be a common mutation within the Lebanese population...
Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpuraAref Chehal
Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Box 113-6044, Beirut 1107 2802, Lebanon
Hemoglobin 26:345-51. 2002..The dramatic response to therapy with plasma exchange, a treatment often effective in TTP, suggests a similarity in pathophysiology of micro-vascular occlusion and multi-organ failure in sickle cell disease...
IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormalityA Chehal
Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Clin Lab Haematol 25:187-90. 2003..The clinical characteristics of a patient diagnosed with IgM myeloma, and his excellent response to treatment are reported here...
Breast cancer in Lebanon. Increased age-adjusted incidence rates in younger-aged groups at presentation: implications for screening and for Arab-American ethnic groupsN S El Saghir
American University of Beirut Medical Center, Lebanon
Ethn Dis 15:S1-11-2. 2005
Familial antiphospholipid antibodies and acquired circulating anticoagulantsI Elhajj
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Lupus 13:812-4. 2004....
Idiopathic thrombocytopenic purpura and ovarian cancerA Chehal
Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Eur J Gynaecol Oncol 24:539-40. 2003..We report a case of a 47-year-old woman diagnosed with ovarian cancer who presented with abdominal distention and thrombocytopenia. Her clinical course and the mechanisms of thrombocytopenia are discussed...
Endometrial metastasis from signet-ring breast carcinoma: case reportA Chehal
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Eur J Gynaecol Oncol 23:563-4. 2002..The patient presented with vaginal bleeding and was found to have wide spread metastasis. Endometrial metastasis in patients with signet-ring breast cancer usually denotes a poor prognosis...
Genetic thrombophilia in patients with VTE in eastern Mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making?H Isma'eel
American University of Beirut Medical Center, Beirut, Lebanon
J Thromb Thrombolysis 21:267-70. 2006..Therefore the aim of this study was to describe the experience of a tertiary care center in thrombophilia work up among patients diagnosed with VTE...
Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significanceA Taher
Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
Lupus 12:854-6. 2003....
SAECG parameters and left ventricular chamber sizes: lesson from anemia conditions in thalassemia major patientsAli Taher
Int J Cardiol 113:E102-4. 2006
Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patientsHussain Isma'eel
American University of Beirut Medical Center
J Thromb Thrombolysis 22:121-3. 2006..Lebanon is known to harbor sickle cell disease, thalassemia and sickle beta-thalassemia hemoglobinopathy patients along with a documented high prevalence of genetic thrombophilia mutations...
High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in LebanonAli Taher
Thromb Haemost 89:945-6. 2003
Isolated thrombocytopenia associated with hydroxyurea/deferiprone (L1) therapy in a sickle beta thalassemia patientMarwan Sheikh-Taha
Lebanese American University; Byblos, Lebano
Haematologica 91:ECR25. 2006
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromesElias Jabbour
Department of Leukemia, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 112:1089-95. 2008..Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year...
Iron chelation in thalassemia: combined or monotherapy? The Egyptian experienceAmal El-Beshlawy
Faculty of Medicine, Cairo University, 32 Falaky Street, Bab El Louk, Cairo, Egypt
Ann Hematol 87:545-50. 2008..Toxicity of DFP was mild to moderate and acceptable; most commonly, transient arthropathy and nausea/vomiting were observed. Thus, combination therapy has shown to be effective in reducing iron overload in thalassemia patients...
Febrile neutropenia and hemorrhagic stroke in a thalassemia major patientMarwan Sheikh Taha
Lebanese American University, Byblos, Lebanon
Hemoglobin 31:499-501. 2007....
Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood: comment on the article by Brunner et alAli Taher
Arthritis Rheum 46:1410. 2002
Improvement of cardiac function in thalassemia major treated with L-carnitineAmal El-Beshlawy
Hematology Clinic, New Cairo University Children Hospital, Cairo, Egypt
Acta Haematol 111:143-8. 2004..Chronic anemia and the tissue hypoxia it induces impair free fatty acid oxidation and ATP production in myocardial cells. The use of L-carnitine, a butyric acid derivative, may help overcome some of these defects...
Thrombotic thrombocytopenic purpura in a patient with Behçet's diseaseFadi I Jabr
Arthritis Rheum 48:1468-9; author reply 1469. 2003
